566 related articles for article (PubMed ID: 22736923)
1. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
2. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
[TBL] [Abstract][Full Text] [Related]
3. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
[TBL] [Abstract][Full Text] [Related]
4. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S
Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
7. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
9. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
Toson EA; Shiha GE; Abdelgaleel AE
Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
[TBL] [Abstract][Full Text] [Related]
10. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
[TBL] [Abstract][Full Text] [Related]
11. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
12. Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C.
Abdelsameea E; Alsebaey A; Abdel-Razek W; Ehsan N; Morad W; Salama M; Waked I
Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1553-1558. PubMed ID: 31972660
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
14. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta.
Kalkan Ç; Yılmaz Y; Erdoğan BD; Savaş B; Yurdcu E; Çalışkan A; Keskin O; Gencdal G; Zeybel M; Törüner M; Bozdayi AM; Idilman R; Yurdaydin C
J Viral Hepat; 2023 May; 30(5):406-416. PubMed ID: 36651603
[TBL] [Abstract][Full Text] [Related]
16. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive markers for staging fibrosis in chronic delta hepatitis.
Takyar V; Surana P; Kleiner DE; Wilkins K; Hoofnagle JH; Liang TJ; Heller T; Koh C
Aliment Pharmacol Ther; 2017 Jan; 45(1):127-138. PubMed ID: 27813124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
